Gilead Sciences to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Truist Securities Downgrades Gilead Sciences (GILD) to Hold
February 22, 2024 6:04 AM ESTTruist Securities analyst Robyn Karnauskas downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Hold with a price target of $82.00 (from $91.00).
The analyst comments "We view GILD/RCUS (RCUS, Buy) re-strategizing to focus on chemo combos in lung and other lrg markets as smart,... More
